Close Menu

Adding to all those other "You know your science has hit the mainstream when..." signs, the Economist has an article on epigenomics. The story reports on the epigenomics program that's part of the NIH Roadmap, and in particular work from Ryan Lister and Mattia Pelizzola at the Salk Institute who studied epigenomics in embryonic stem cells.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.